- Home
- RYTM vs URBN Comparison
RYTM vs URBN Comparison
Compare RYTM & URBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RYTM
- URBN
- Stock Information
- Founded
- RYTM 2008
- URBN 1970
- Country
- RYTM United States
- URBN United States
- Employees
- RYTM 283
- URBN N/A
- Industry
- RYTM Biotechnology: Pharmaceutical Preparations
- URBN Clothing/Shoe/Accessory Stores
- Sector
- RYTM Health Care
- URBN Consumer Discretionary
- Exchange
- RYTM Nasdaq
- URBN Nasdaq
- Market Cap
- RYTM 6.9B
- URBN 6.8B
- IPO Year
- RYTM 2017
- URBN 1993
- Fundamental
- Price
- RYTM $102.12
- URBN $70.77
- Analyst Decision
- RYTM Strong Buy
- URBN Buy
- Analyst Count
- RYTM 13
- URBN 11
- Target Price
- RYTM $101.92
- URBN $81.91
- AVG Volume (30 Days)
- RYTM 550.8K
- URBN 2.3M
- Earning Date
- RYTM 11-04-2025
- URBN 08-27-2025
- Dividend Yield
- RYTM N/A
- URBN N/A
- EPS Growth
- RYTM N/A
- URBN 55.85
- EPS
- RYTM N/A
- URBN 5.10
- Revenue
- RYTM $156,287,000.00
- URBN $5,832,231,000.00
- Revenue This Year
- RYTM $44.69
- URBN $10.58
- Revenue Next Year
- RYTM $63.53
- URBN $6.73
- P/E Ratio
- RYTM N/A
- URBN $13.88
- Revenue Growth
- RYTM 53.55
- URBN 9.63
- 52 Week Low
- RYTM $45.91
- URBN $33.86
- 52 Week High
- RYTM $106.52
- URBN $80.71
- Technical
- Relative Strength Index (RSI)
- RYTM 60.62
- URBN 44.49
- Support Level
- RYTM $101.45
- URBN $65.50
- Resistance Level
- RYTM $106.52
- URBN $71.36
- Average True Range (ATR)
- RYTM 3.12
- URBN 3.04
- MACD
- RYTM -0.43
- URBN -0.81
- Stochastic Oscillator
- RYTM 65.84
- URBN 39.04
About RYTM Rhythm Pharmaceuticals Inc.
Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. It is engaged in the development and commercialization of therapies for patients with rare diseases. The company is focused on its melanocortin-4 receptor (MC4R) agonists, including its main asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. Geographically the company generates its revenue from the United States and internationally with the majority being generated from the United States.
About URBN Urban Outfitters Inc.
Founded in 1970, Philadelphia-based Urban Outfitters is an apparel and home goods retailer that operates more than 700 stores and e-commerce in the United States, which accounts for about 87% of sales, and other regions. Its retail nameplates are Urban Outfitters (23% of fiscal 2025 sales), Free People/Movement (26%), and Anthropologie (44%). Retail accounted for 88% of fiscal 2025 revenue, but Urban Outfitters also sells products through a wholesale operation, owns some restaurants, and operates a fast-growing clothing rental and resale business called Nuuly (7% of sales). Urban Outfitters primarily markets to young adults and offers products in categories such as apparel (66% of sales), home goods (16% of sales), accessories (13% of sales), and more.